Genetically engineered bacterium for producing L-aspartic acid through fermentation and construction method and application thereof
A technology of genetically engineered bacteria and aspartic acid, which is applied to the field of genetically engineered bacteria that ferment L-aspartic acid and its construction, can solve the problem of high cost of raw materials, low product concentration, and low economical implementation of industrialization. problems, to achieve the effect of improving yield and concentration, green process route, significant economic and social benefits
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0029] This example illustrates the method of constructing the target plasmid pTarget T2 containing gene targeting sequence and homologous recombination fragment by overlapping PCR technology.
[0030] 1. Using the nucleotide sequences shown in SEQ ID NO: 2 and SEQ ID NO: 3 as primers and plasmid pTarget F as a template, linear fragment 1 was obtained by PCR amplification;
[0031] 2. The linear fragment 1 was digested with SpeI and ligated, and the ligated product was transformed into a competent medium, and the positive recombinant was screened out on the LB plate coated with spectinomycin;
[0032] 3. The positive recombinants were inoculated in LB liquid culture and multiplied with spectinomycin, and then the plasmid was extracted to obtain the pTarget T1 plasmid;
[0033] 4. Using the nucleotide sequences shown in SEQ ID NO: 4 and SEQ ID NO: 5 as primers, and the E. coli genome as a template, linear fragment 2 was obtained by PCR amplification; using SEQ ID NO: 6 and SEQ ...
Embodiment 2
[0038] This example illustrates the method of using arabinose to induce the preparation of a competent protein containing cas9, and the specific steps include:
[0039] 1. Introduce the pCas plasmid into the Escherichia coli recombinant bacteria to be gene-edited. The preservation number is CGMCC NO: 2301, and use the LB plate of kanamycin to screen out positive recombinants;
[0040] 2. Induce the positive recombinants in the above steps with 30mM arabinose, and shake the bacteria for 3-4 hours at 30°C to prepare competent cells with an OD value of about 0.4-0.6.
Embodiment 3
[0042] This example illustrates the use of CRISPR / Cas9 technology to knock out parental Escherichia coli aceBAC repressor gene iCR the process of.
[0043] 1. Introduce the pTarget T2 plasmid into competent cells containing cas9 protein, and select positive recombinants with LB plates added with spectinomycin and kanamycin;
[0044] 2. Identify the above-mentioned positive recombinants by PCR, and screen out the target genetically engineered strains.
[0045]3. After the positive recombinants screened in step 2 were transferred to the LB medium containing kanamycin induced by IPTG and cultured, they were transferred to the LB medium plate containing kanamycin and simultaneously containing kanamycin. Namycin and spectinomycin LB medium plate, screened out recombinant strains that have degraded the pTarget T2 plasmid.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com